Immunohistochemical and ultrastructural examination of smooth muscle cells in aortocoronary saphenous vein grafts

Angiology

Volumn 48, Issue 5, 1997, Pages 381-390

  Yamada, Takahiro ^a   Shiraishi, Ryo ^a   Taki, Kenji ^a   Nakano, Shigeo ^a   Tokunaga, Osamu ^a   Itoh, Tsuyoshi ^a  

^a SAGA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DESMIN; VIMENTIN;

ARTICLE; CORONARY ARTERY BYPASS GRAFT; DISEASE ASSOCIATION; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; PHENOTYPE; SAPHENOUS VEIN GRAFT; SMOOTH MUSCLE FIBER;

EID: 0031008101     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331979704800502     Document Type: Article

References (24)

1. Vlodaver Z, Edwards JE: Pathologic changes in aortic-coronary arterial saphenous vein grafts. Circulation 44:719-728, 1971.
2. Kern WH, Dermer GB, Lindesmith GG: The intimal proliferation in aortic-coronary saphenous vein grafts. Light and electron microscopic studies. Am Heart J 84:771-777, 1972.
3. Kern WH, Wells WJ, Meyer BW: The pathology of surgically excised aortocoronary saphenous vein bypass grafts. Am J Surg Pathol 5:491-496, 1981.
4. Smith SH, Geer JC: Morphology of saphenous veincoronary artery bypass grafts. Seven to 116 months after surgery. Arch Pathol Lab Med 107:13-18, 1983.
5. Kalan JM, Roberts WC: Morphologic findings in saphenous veins used as coronary arterial bypass conduits for longer than 1 year. Necropsy analysis of 53 patients, 123 saphenous veins, and 1865 five millimeter segments of veins. Am Heart J 119:1164-1184, 1990.
6. Ip JH, Fuster V, Badimon L, et al: Syndromes of accelerated atherosclerosis: Role of vascular injury and smooth muscle cell proliferation. J Am Coll Cardiol 15:1667-1687, 1990.
7. Thyberg J, Hedin U, Sjölund M, et al: Regulation of differentiated properties and proliferation of arterial smooth muscle cells. Arteriosclerosis 10:966-990, 1990.
8. Raines EW, Ross R: Smooth muscle cells and the pathogenesis of the lesions of atherosclerosis. Br Heart J 69 (Suppl):30-37, 1993.
9. Kocher O, Huttner I, Gabbiani G: Atherosclerosis: Cellular aspects. In: Disease of the Arterial Wall, ed. by Camilleri JP, Berry CL, Fiessinger JN, et al. Tokyo: Springer-Verlag, 1989, pp 167-183.
10. Kocher O, Skalli O, Bloom WS, et al: Cytoskeleton of rat aortic smooth muscle cells. Normal conditions and experimental intimal thickening. Lab Invest 50:645-652, 1984.
11. Mosse PRL, Campbell GR, Wang ZL, et al: Smooth muscle phenotypic expression in human carotid arteries. I. Comparison of cells from diffuse intimai thickenings adjacent to atheromatous plaques with those of the media. Lab Invest 53:556-562, 1985.
12. Osborn M, Caselitz J, Puschel K, et al: Intermediate filament expression in human vascular smooth muscle and in arteriosclerotic plaques. Virchows Archiv [A] 411:449-458, 1987.
13. Babaev VR, Bobryshev YV, Stenina OV, et al: Heterogeneity of smooth muscle cells in atheromatous plaque of human aorta. Am J Pathol 136:1031-1042, 1990.
14. Takaichi S, Yutani C, Fujita H, et al: Ultrastructural studies on the phenotypic modulation of human intimal smooth muscle cells. Atherosclerosis 100:197-211, 1993.
15. Yamada T, Itoh T, Nakano S, et al: Time-dependent thickening of the intima in aortocoronary saphenous vein grafts and clinicopathological analysis of 24 patients. Heart Vessels 10:41-45, 1995.
16. Kishikawa H, Shimokama T, Watanabe T: Localization of T lymphocytes and macrophages expressing IL-1, IL-2 receptor, IL-6 and TNF in human aortic intima. Role of cell-mediated immunity in human atherogenesis. Virchows Archiv [A] 423:433-442, 1993.
17. Yamada T, Fan J, Shimokama T, et al: Induction of fatty streak-like lesions in vitro using a culture model system simulating arterial intima. Am J Pathol 141:1435-1444, 1992.
18. Gabbiani G, Schmid E, Winter S, et al: Vascular smooth muscle cells differ from other smooth muscle cells: Predominance of vimentin filaments and a specific a-type actin. Proc Natl Acad Sci USA 78:298-302, 1981.
19. Frank ED, Warren L: Aortic smooth muscle cells contain vimentin instead of desmin. Proc Natl Acad Sci USA 78:3020-3024, 1981.
20. Ueda M, Becker AE, Tsukada T, et al: Fibrocellular tissue response after percutaneous transluminal coronary angioplasty. An immunocytochemical analysis of the cellular composition. Circulation 83:1327-1332, 1991.
21. Wanibuchi H, Ueda M, Dingemans KP, et al: The response to percutaneous transluminal coronary angioplasty: An ultrastructural study of smooth muscle cells and endothelial cells. Cardiovasc Pathol 1:295-306, 1992.
22. London SM, Mayberg MR: Kinetics of bromodeoxyuridine uptake by smooth muscle cells after arterial injury. J Vase Res 31:247-255, 1994.
23. van der Wal AC, Becker AE, Elbers JRJ, et al: An immunocytochemical analysis of rapidly progressive atherosclerosis in human vein grafts. Eur J Cardiothorac Surg 6:469-474, 1992.
24. Hagen PO, Davies MG, Schuman RW, et al: Reduction of vein graft intimal hyperplasia by ex vivo treatment with desferrioxamine manganese. J Vasc Res 29:405-409, 1992.